Chemours (CC) Misses Q4 EPS by 12c

Chemours (NYSE: CC) reported Q4 EPS of $0.00, $0.12 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.26 billion.

For earnings history and earnings-related data on Chemours (CC) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Raymond James Previews Charles Schwab Corp. (SCHW) Earnings: 'Elevated Trading Volumes Drives Trading Revenue Upside'
• UBS Reiterates Neutral Rating on Buckle, Inc. (BKE)